LISA BLOXHAM: Open Payments
NPI 1366904740 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$732 in 17 payments from 10 companies in 2025. Trend: 2023 $745 · 2024 $1,041 · 2025 $732
Food & beverage: $732
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $236 |
| Myriad Genetic Laboratories, Inc. | 2 | $152 |
| Daiichi Sankyo Inc. | 3 | $146 |
| Novartis Pharmaceuticals Corporation | 2 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Aveo Pharmaceuticals, Inc. | 1 | $36 |
| Geron Corporation | 1 | $20 |
| PFIZER INC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Eisai Inc. | 1 | $16 |
Products named: MYRISK, DATROWAY, TECVAYLI, ERLEADA, Nubeqa, FOTIVDA, LUTATHERA, RYBREVANT.
Industry payments across OK — which companies pay providers there.
